“UNDIAGNOSED DIABETES MELLITUS IN ACUTE CORONARY SYNDROME (ACS) PATIENTS”

Main Article Content

Dr Obaidullah
Dr Mahwash Mengal
Dr Abdul Jabbar
Dr Asma Shaheer
Dr Muhammad Farid
Momin Khan

Keywords

Acute Coronary Syndrome; Undiagnosed Diabetes Mellitus; Prediabetes; Cardiovascular Risk Factors; Glycemic Screening

Abstract

Background: Acute coronary syndrome (ACS) continues to be the principal cause of sickness and death all over the world. It has been firmly established that diabetes mellitus increases the risk of coronary artery disease, a large number of patients are always unidentified at the time they have an acute cardiac event. Unrecognized diabetes can negatively affect the seriousness, therapeutic approach, and outcome of ACS, especially in regions where healthcare facilities and metabolic screening are ‍‌scarce.


Objective: Determining how often undiagnosed diabetes mellitus occurs among patients presenting with acute coronary syndrome and assessing the association of this condition with clinical and metabolic characteristics at ‌admission.


Methods: This cross-sectional study at the hospital was carried out over a six-month period from April, 2025 to September, 2025 at the Saidu Group of Teaching Hospital Swat. Participating in the research were 180 patients who were diagnosed with ACS and had no previous history of diabetes. Each patient's demographic and clinical details were noted. On the day of admission and within the first 24 hours, fasting plasma glucose and glycated hemoglobin (HbA1c) levels were determined. The presence of undiagnosed diabetes was indicated by the fulfillment of the standard diagnostic criteria. Researchers used both descriptive and inferential statistics to analyze the ‍‌data.


Results: Among the 180 patients with acute coronary syndrome, 62 (34.4%) were first-time diagnosed with diabetes mellitus, and 46 (25.6%) had prediabetes. The majority of acute coronary syndrome cases presented with ST-elevation myocardial infarction, especially in those patients who were not aware of their diabetes condition. Patients with newly identified diabetes showed a much higher occurrence of both hypertension and dyslipidemia as compared to the normoglycemic ‍‌group.


Conclusion: The majority of ACS patients were found to have undiagnosed diabetes mellitus. It is important to perform a routine glycemic screening once ACS patients are presented for an early diagnosis, and the implementation of effective secondary prevention strategies to improve cardiovascular ‍‌outcomes.


 


 

Abstract 0 | PDF Downloads 0

References

1. Kazim AH, Shahzad M, Rasheed S, Bilal A, Sadiq N, Sadiq T. Undiagnosed diabetes mellitus in acute coronary syndrome (ACS) patients. Pakistan Journal of Medical & Health Sciences. 2022;16(09):365.
2. Drobek N, Sowa P, Jankowski P, Haberka M, Gąsior Z, Kosior D, et al. Undiagnosed diabetes and prediabetes in patients with chronic coronary syndromes—An alarming public health issue. Journal of Clinical Medicine. 2021;10(9):1981.
3. Gutierrez-Mariscal FM, Alcala-Diaz JF, Quintana-Navarro GM, De la Cruz-Ares S, Torres-Pena JD, Cardelo MP, et al. Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: From the CORDIOPREV study. European Journal of Nutrition. 2023;62(4):1903–1913.
4. Ahmed W, Muhammad T, Maurya C, Akhtar SN. Prevalence and factors associated with undiagnosed and uncontrolled heart disease among middle-aged and older Indian adults. PLoS One. 2023;18(6):e0287455.
5. Farhan S, Redfors B, Maehara A, McAndrew T, Ben-Yehuda O, De Bruyne B, et al. Relationship between insulin resistance, coronary plaque, and clinical outcomes in acute coronary syndromes: The PROSPECT study. Cardiovascular Diabetology. 2021;20(1):10.
6. Johny E, Bhaskar P, Alam MJ, Kuladhipati I, Das R, Adela R. Platelet-mediated inflammation in coronary artery disease with type 2 diabetes patients. Journal of Inflammation Research. 2021:5131–5147.
7. Yang T, Liu Y, Li L, Zheng Y, Wang Y, Su J, et al. Triglyceride-to-HDL cholesterol ratio and risk of prediabetes and type 2 diabetes in coronary heart disease patients. Cardiovascular Diabetology. 2022;21(1):93.
8. Wu W, Jia C, Xu X, He Y, Xie Y, Zhou Y, et al. Impact of platelet-to-HDL cholesterol ratio on long-term mortality in coronary artery disease patients. Journal of Inflammation Research. 2024:2731–2744.
9. Podadera-Herreros A, Alcala-Diaz JF, Gutierrez-Mariscal FM, Jimenez-Torres J, De la Cruz-Ares S, Arenas-de Larriva AP, et al. Long-term dietary patterns and kidney function in coronary heart disease patients: CORDIOPREV trial. Clinical Nutrition. 2022;41(2):552–559.
10. Li M, Duan L, Cai Y, Hao B, Chen J, Li H, Liu H. Prognostic value of soluble ST2 in coronary artery disease patients with and without diabetes. Cardiovascular Diabetology. 2021;20(1):49.
11. Yi C, Junyi G, Fengju L, Qing Z, Jie C. Association between lipoprotein(a) and peripheral arterial disease in CABG patients. Clinical Cardiology. 2023;46(5):512–520.
12. Grines CL, Klein AJ, Bauser-Heaton H, Alkhouli M, Katukuri N, Aggarwal V, et al. Racial and ethnic disparities in coronary and vascular heart disease. Catheterization and Cardiovascular Interventions. 2021;98(2):277–294.
13. Yubero-Serrano EM, Alcalá-Diaz JF, Gutierrez-Mariscal FM, Arenas-de Larriva AP, Peña-Orihuela PJ, Blanco-Rojo R, et al. Cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients. Cardiovascular Diabetology. 2021;20(1):72.

14. Lin X, Song W, Zhou Y, Gao Y, Wang Y, Wang Y, et al. Urine albumin-creatinine ratio and cardiovascular mortality in coronary artery disease patients. Cardiovascular Diabetology. 2023;22(1):203.
15. Yu X, Wang Y, Yang R, Wang Z, Wang X, Wang S, et al. Trimethylamine N-oxide predicts cardiovascular events in coronary artery disease patients with diabetes. Frontiers in Endocrinology. 2024;15:1360861.
16. De la Cruz-Ares S, Gutierrez-Mariscal FM, Alcala-Diaz JF, Quintana-Navarro GM, Podadera-Herreros A, Cardelo MP, et al. Protein intake and incidence of type 2 diabetes in coronary heart disease patients. Nutrients. 2021;13(4):1217.
17. Mosteoru S, Kundnani NR, Rus A, Ilin S, Ciocan V, Albulescu N, et al. Importance of secondary prevention in coronary heart disease. Medicina. 2025;61(11):2011.
18. González-Juanatey C, Anguita-Sánchez M, Barrios V, Núñez-Gil I, Gómez-Doblas JJ, García-Moll X, et al. Major adverse cardiovascular events in coronary type 2 diabetic patients. Journal of Clinical Medicine. 2022;11(20):6004